Clinical Trial Update: Benefits of Injectable Abatacept Using Magnetic Resonance Imaging (MRI) in Rheumatoid Arthritis (RA) Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the benefits of injectable abatacept in rheumatoid arthritis patients using MRI, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ORENCIA (ABATACEPT)

Snippet

Sponsor: Arthritis & Rheumatic Disease Specialties Research | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2017-03-13